Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19318992 | 1.00 | LMNA (0.52) | LMNAKMT2AALDH1A1TAAR1MAPT | |
| SCHEMBL3031493 | 1.00 | LMNA (0.52) | LMNAKMT2AALDH1A1TAAR1MAPT | |
| SCHEMBL7852169 | 1.00 | LMNA (0.52) | LMNAKMT2AALDH1A1TAAR1MAPT | |
| SCHEMBL23698034 | 1.00 | LMNA (0.52) | LMNAKMT2AALDH1A1TAAR1MAPT | |
| SCHEMBL187221 | 1.00 | LMNA (0.52) | LMNAKMT2AALDH1A1TAAR1MAPT | |
| SCHEMBL23176525 | 1.00 | LMNA (0.52) | LMNAKMT2AALDH1A1TAAR1MAPT | |
| SCHEMBL1004125 | 1.00 | LMNA (0.52) | LMNAKMT2AALDH1A1TAAR1MAPT | |
| SCHEMBL3045980 | 1.00 | LMNA (0.52) | LMNAKMT2AALDH1A1TAAR1MAPT | |
| SCHEMBL407172 | 0.97 | LMNA (0.50) | LMNAKMT2AALDH1A1TAAR1MAPT | |
| SCHEMBL31208131 | 0.97 | LMNA (0.50) | LMNAKMT2AALDH1A1TAAR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3467022-A1 | PROPYLENE-BASED RESIN COMPOSITION AND INJECTION-MOLDED OBJECT THEREOF | Sumitomo Chemical Company, Limited (JP) | 2019-04-10 | — | — | EP | disclosed |
| US-20070196859-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2007-08-23 | — | — | US | disclosed |
| US-20070196859-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196859-A1 | Novel antibacterial agents | ENGASE, PEPD, PGLS | LMNA 3455/4885KMT2A 3557/4885ALDH1A1 1953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.